Doravirine in Human Immunodeficiency Virus -Infected Children Ages 4 Weeks to <12 Years and <45 kg
This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 weeks to